Lenced 4 mg

Lenced 4mg Capsule contains the active ingredient Lenvatinib. This medication is a tyrosine kinase inhibitor used for progressive or advanced thyroid cancer when radioactive iodine therapy is ineffective. Additionally, it is prescribed for liver cancer patients who have not received prior treatment and are not candidates for surgical intervention.

Anaplastic Thyroid Carcinoma, a form of advanced thyroid cancer, typically affects individuals over the age of 60. Symptoms include an enlarged and hardened thyroid gland, along with voice hoarseness resulting from nerve paralysis in the larynx. Hepatocellular carcinoma, or liver cancer, often arises from existing liver issues such as cirrhosis or chronic hepatitis B infection.

Patients with a history of allergic reactions to Lenced 4mg Capsule or any of its ingredients should avoid using this medication. It is important for patients to notify their dentist or oral surgeon about their use of Lenced 4mg Capsule, as it may hinder wound healing and elevate the risk of bleeding.